Baidu
map

25张高清版联盟地区药品集采中标地图

2019-09-29 佚名 医药魔方

25张高清版联盟地区药品集采中标地图




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735524, encodeId=e1b21e355240c, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Sat May 30 09:53:00 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416538, encodeId=59c114165381c, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Tue Oct 01 06:53:00 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496673, encodeId=08d614966e34c, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Tue Oct 01 06:53:00 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
    2020-05-30 xsm929
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735524, encodeId=e1b21e355240c, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Sat May 30 09:53:00 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416538, encodeId=59c114165381c, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Tue Oct 01 06:53:00 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496673, encodeId=08d614966e34c, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Tue Oct 01 06:53:00 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1735524, encodeId=e1b21e355240c, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Sat May 30 09:53:00 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416538, encodeId=59c114165381c, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Tue Oct 01 06:53:00 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496673, encodeId=08d614966e34c, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Tue Oct 01 06:53:00 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
    2019-10-01 zexyw04

相关资讯

齐鲁回应低空中标、印度瑞迪报价依据……

9月24日,伴随着新国家药品带量采购扩围拟中选结果出炉,中国医药行业在向新生态转变的速度进一步加快。

Baidu
map
Baidu
map
Baidu
map